Summary results for ivermectin for COVID-19 from the large TOGETHER trial were just released No benefit whatsoever for ivermectin on risk of hospitalization or mortality in a mild outpatient grouppic.twitter.com/5eZj0pc5V6
You can add location information to your Tweets, such as your city or precise location, from the web and via third-party applications. You always have the option to delete your Tweet location history. Learn more
What anti virals you suggest sir for ppl who get medium to severe COVID? Anything expected in near future?
Thanks. Did you choose the headline too, "unlikely... any benefit", as perhaps this suffers from what, in the Cult of Statistical Significance, was called 'the sizeless stare' - i.e. making binary judgement - effect/no effect- rather than something more nuanced?
The point estimates appear to suggest an RR around 0.8. If further well-controlled studies are conducted and similar the pooled estimate CI likely to keep left of 1. But if cost and toxicology risk both v. low from a decision perspective perhaps current evidence is enough?...
Do you think making these types of tweets are helpful?
What about if given in the beginning after positive test? How sick were the people in the study? What about monoclonal antibodies research?
Have they released the published version of the study yet?
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.